COMPANY OVERVIEW

Experienced Investors

  • Founded by two real estate professionals with a combined 35 years of life science and medical office experience
  • Principals have acquired and managed over 25 properties valued over $4 billion and 10 million SF in North America and Europe
  • Breadth of investment experience spans multiple market cycles and assets classes
  • Long-term relationships in development, leasing, and management of life science and medical office assets provide a unique competitive advantage

 

Investment Strategy

  • Identify undervalued assets in strategic locations to exploit growth in the life science sector and recognize long-term value
  • Gain first-mover advantage in an asset class with high barriers to entry and few investors with comparable industry knowledge and expertise
  • Macro-driven strategy to invest around demographic trends, including in markets with high density and aggregate spending
  • Focus on markets with high intellectual capital, in particular with research-driven institutions where ample funding for R&D and a concentration of researchers are faced with inadequate facilities
  • Strategically target second- and third-generation renovations, which benefit from previous tenant investment and speed to occupancy but are frequently overlooked by investors

Acquisitions Milestones

14 Wall Street

New York, NY
Medical and Creative Office

1951 NW 7th Ave

Miami, FL
Lab Facility

Center of Excellence

Bridgewater, NJ
Life Science Campus

14200 Shady Grove

Rockville MD, NY
Life Science Building

156 William Street

New York, NY
Medical Office Conversion

825 Washington Street

Norwood, MA
Medical Office/Lab

Pacific Research Center

Newark, CA
Life Science Campus

907 Market Street

Philadelphia, PA
Medical Office

95 Greene

Jersey City, NJ
Life Science Campus

3 Blackfan Circle

Boston, MA
Life Science Building

130 Shoreline Drive

Boston, MA
Life Science Building

7 Powderhorn

Warren, NJ
Life Science Campus

* All properties acquired while at Capstone Equities, Thor Equities, and Biomed Realty Trust (Blackstone)